SCHEMBL2880877

SCHEMBL2880877

C=C[CH]c1n[nH]c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.48
▸ GAA P10253 2/20 0.48
▸ PDPK1 O15530 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.46
▸ IDO1 P14902 3/20 0.46
▸ TTK P33981 2/20 0.46
▸ MAPK10 P53779 2/20 0.46
▸ ALPL P05186 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP1A2 P05177 1/20 0.42
▸ LRRK2 Q5S007 3/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ AURKA O14965 3/20 0.38
▸ FGFR1 P11362 2/20 0.38
▸ FLT1 P17948 2/20 0.38
▸ ITK Q08881 2/20 0.38
▸ YTHDC1 Q96MU7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL298966 0.84 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL31190846 0.84 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL7331167 0.76 KDM4E (0.57) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL29643994 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL730639 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL7331545 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL7329986 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL5693192 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL14412480 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL561564 0.76 KDM4E (0.52) KDM4EGAAPDPK1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105218516-A Therapeutic compounds and related methods of use OTSUKA PHARMA CO LTD 2016-01-06 — — CN claimed
CN-102883723-A Therapeutic compounds and related methods of use GALENEA CORP 2013-01-16 — — CN claimed
EP-2212330-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) Choongwae Pharma Corporation (KR) 2010-08-04 — — EP claimed
WO-2009051397-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) CHOONGWAE PHARMA CORPORATION (KR) 2009-04-23 — — WO claimed
US-7071199-B1 Kinase inhibitors as therapeutic agents ABBOTT GMBH & CCO. KG (DE) 2006-07-04 — — US claimed
CN-105218516-A Therapeutic compounds and related methods of use OTSUKA PHARMA CO LTD 2016-01-06 — — CN disclosed
CN-102883723-B Therapeutic compounds and related methods of use OTSUKA PHARMACEUTICAL CO.,LTD. (JP) 2015-09-16 — — CN disclosed
CN-102883723-A Therapeutic compounds and related methods of use GALENEA CORP 2013-01-16 — — CN disclosed
EP-2212330-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) Choongwae Pharma Corporation (KR) 2010-08-04 — — EP disclosed
WO-2009051397-A9 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) CHOONGWAE PHARMA CORPORATION (KR) 2010-05-27 — — WO disclosed
WO-2009051397-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) CHOONGWAE PHARMA CORPORATION (KR) 2009-04-23 — — WO disclosed
EP-0739338-A4 NOVEL SERINE PROTEASE INHIBITORS: DERIVATIVES OF ISOTHIAZOLIDIN-3-ONE-1,1 DIOXIDE AND 3-OXO-1,2,5-THIADIAZOLIDINE-1,1-DIOXIDE UNIV WICHITA STATE (US) 1997-03-26 — — EP disclosed
EP-0739338-A1 NOVEL SERINE PROTEASE INHIBITORS: DERIVATIVES OF ISOTHIAZOLIDIN-3-ONE-1,1 DIOXIDE AND 3-OXO-1,2,5-THIADIAZOLIDINE-1,1-DIOXIDE THE WICHITA STATE UNIVERSITY (US) 1996-10-30 — — EP disclosed
WO-1995018797-A1 NOVEL SERINE PROTEASE INHIBITORS: DERIVATIVES OF ISOTHIAZOLIDIN-3-ONE-1,1 DIOXIDE AND 3-OXO-1,2,5-THIADIAZOLIDINE-1,1-DIOXIDE THE WICHITA STATE UNIVERSITY (US) 1995-07-13 — — WO disclosed
Send feedback